Literature DB >> 29766007

Autoimmunity in the Abdominal Aortic Aneurysm and its Association with Smoking.

M David Tilson1.   

Abstract

Smoking increases the risk of abdominal aortic aneurysm (AAA) in both humans and mice, although the underlying mechanisms are not completely understood. An adventitial aortic antigen, AAAP-40, has been partially sequenced. It has motifs with similarities to all three fibrinogen chains and appears to be connected in evolution to a large family of proteins called fibrinogen-related proteins. Fibrinogen may undergo non-enzymatic nitration, which may result from exposure to nitric oxide in cigarette smoke. Nitration of proteins renders them more immunogenic. It has recently been reported that anti-fibrinogen antibody promotes AAA development in mice. Also, anti-fibrinogen antibodies are present in patients with AAA. These matters are reviewed in the overall context of autoimmunity in AAA. The evidence suggests that smoking amplifies an auto-immune reaction that is critical to the pathogenesis of AAA.

Entities:  

Keywords:  Abdominal aortic aneurysm; Autoimmunity; Fibrinogen; Nitric oxide; Smoking

Year:  2017        PMID: 29766007      PMCID: PMC5942549          DOI: 10.12945/j.aorta.2017.17.693

Source DB:  PubMed          Journal:  Aorta (Stamford)        ISSN: 2325-4637


  70 in total

1.  Expression of two novel recombinant proteins from aortic adventitia (kappafibs) sharing amino acid sequences with cytomegalovirus.

Authors:  K J Ozsvath; H Hirose; S Xia; D Chew; J Knoetgen; M D Tilson
Journal:  J Surg Res       Date:  1997-05       Impact factor: 2.192

2.  Decline of the atherogenic theory of the etiology of the abdominal aortic aneurysm and rise of the autoimmune hypothesis.

Authors:  M David Tilson
Journal:  J Vasc Surg       Date:  2016-09-12       Impact factor: 4.268

3.  Complement activation and subclassification of tissue immunoglobulin G in the abdominal aortic aneurysm.

Authors:  J F Capella; D C Paik; N X Yin; J E Gervasoni; M D Tilson
Journal:  J Surg Res       Date:  1996-09       Impact factor: 2.192

4.  Fifty families with abdominal aortic aneurysms in two or more first-order relatives.

Authors:  M D Tilson; M R Seashore
Journal:  Am J Surg       Date:  1984-04       Impact factor: 2.565

5.  The role of inflammation in nonspecific abdominal aortic aneurysm disease.

Authors:  C M Brophy; J M Reilly; G J Smith; M D Tilson
Journal:  Ann Vasc Surg       Date:  1991-05       Impact factor: 1.466

Review 6.  Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins.

Authors:  Hitoshi Ohmori; Naoki Kanayama
Journal:  Autoimmun Rev       Date:  2004-12-30       Impact factor: 9.754

7.  Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response.

Authors:  A E Koch; G K Haines; R J Rizzo; J A Radosevich; R M Pope; P G Robinson; W H Pearce
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

8.  Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects.

Authors:  Rafael Radi
Journal:  Acc Chem Res       Date:  2012-11-16       Impact factor: 22.384

9.  Demonstration of interstitial collagenase in abdominal aortic aneurysm disease.

Authors:  E Irizarry; K M Newman; R H Gandhi; G B Nackman; V Halpern; S Wishner; J V Scholes; M D Tilson
Journal:  J Surg Res       Date:  1993-06       Impact factor: 2.192

10.  Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall.

Authors:  K M Newman; J Jean-Claude; H Li; J V Scholes; Y Ogata; H Nagase; M D Tilson
Journal:  J Vasc Surg       Date:  1994-11       Impact factor: 4.268

View more
  1 in total

1.  Genetic polymorphism of HLA-DRB1 alleles in Mexican mestizo patients with abdominal aortic aneurysms.

Authors:  Javier E Anaya-Ayala; Susana Hernandez-Doño; Monica Escamilla-Tilch; Jose Marquez-Garcia; Kemberly Hernandez-Sotelo; Rodrigo Lozano-Corona; Daniela Ruiz-Gomez; Julio Granados; Carlos A Hinojosa
Journal:  BMC Med Genet       Date:  2019-06-07       Impact factor: 2.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.